Efficacy of combined orbital radiation and systemic steroids in the management of Graves’ orbitopathy

Ji Won Kim, Sun Hyup Han, Byeong Jae Son, Tyler Hyungtaek Rim, Ki Chang Keum, Jinsook Yoon

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose: To compare the efficacy and safety of combination therapy with orbital irradiation and systemic steroids versus steroid monotherapy in the management of active Graves’ orbitopathy (GO). Methods: The clinical charts of 127 patients with active inflammation due to GO who received intravenous steroid pulse therapy as a first-line treatment with or without orbital radiotherapy between 2010 and 2014 were reviewed. Patients were divided into two treatment groups: 1) combined orbital radiotherapy and steroid pulse therapy (SRT group) and 2) steroid pulse therapy only (ST group). Primary outcome measures included clinical activity score (CAS); NOSPECS classification; ocular motility impairment; and exophthalmos at 1, 3, 6, and 12 months after treatment. The secondary outcome measure was the change in orbital, extraocular muscle (EOM), and fat volume after treatment measured by orbit computed tomography. Results: Sixty-eight patients were included in the SRT group, and 59 patients were in the ST group. In both treatments, CAS and NOSPECS were significantly reduced. In the comparison of the degree of change from baseline between the groups, the SRT group demonstrated more improvement in NOSPECS and scores of ocular motility. Orbital, EOM, and fat volume significantly decreased in the SRT group; however, only fat volume was reduced in the ST group. Compressive optic neuropathy after treatment developed in 0 % of the SRT group and 3.4 % (2/59) of the ST group. Reactivation of inflammation occurred in 11.8 % (8/68) of the SRT group and 28.8 % (17/59) of the ST group. Conclusions: Orbital radiotherapy in combination with steroid treatment significantly improved ocular motility by reducing EOM volume in patients with active GO.

Original languageEnglish
Pages (from-to)991-998
Number of pages8
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume254
Issue number5
DOIs
Publication statusPublished - 2016 May 1

Fingerprint

Steroids
Radiation
Oculomotor Muscles
Therapeutics
Radiotherapy
Fats
Outcome Assessment (Health Care)
Inflammation
Optic Nerve Diseases
Exophthalmos
Orbit
Group Psychotherapy
Tomography
Safety

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Kim, Ji Won ; Han, Sun Hyup ; Son, Byeong Jae ; Rim, Tyler Hyungtaek ; Keum, Ki Chang ; Yoon, Jinsook. / Efficacy of combined orbital radiation and systemic steroids in the management of Graves’ orbitopathy. In: Graefe's Archive for Clinical and Experimental Ophthalmology. 2016 ; Vol. 254, No. 5. pp. 991-998.
@article{cf0fb70b5d0741c7b0001d2b24c044b8,
title = "Efficacy of combined orbital radiation and systemic steroids in the management of Graves’ orbitopathy",
abstract = "Purpose: To compare the efficacy and safety of combination therapy with orbital irradiation and systemic steroids versus steroid monotherapy in the management of active Graves’ orbitopathy (GO). Methods: The clinical charts of 127 patients with active inflammation due to GO who received intravenous steroid pulse therapy as a first-line treatment with or without orbital radiotherapy between 2010 and 2014 were reviewed. Patients were divided into two treatment groups: 1) combined orbital radiotherapy and steroid pulse therapy (SRT group) and 2) steroid pulse therapy only (ST group). Primary outcome measures included clinical activity score (CAS); NOSPECS classification; ocular motility impairment; and exophthalmos at 1, 3, 6, and 12 months after treatment. The secondary outcome measure was the change in orbital, extraocular muscle (EOM), and fat volume after treatment measured by orbit computed tomography. Results: Sixty-eight patients were included in the SRT group, and 59 patients were in the ST group. In both treatments, CAS and NOSPECS were significantly reduced. In the comparison of the degree of change from baseline between the groups, the SRT group demonstrated more improvement in NOSPECS and scores of ocular motility. Orbital, EOM, and fat volume significantly decreased in the SRT group; however, only fat volume was reduced in the ST group. Compressive optic neuropathy after treatment developed in 0 {\%} of the SRT group and 3.4 {\%} (2/59) of the ST group. Reactivation of inflammation occurred in 11.8 {\%} (8/68) of the SRT group and 28.8 {\%} (17/59) of the ST group. Conclusions: Orbital radiotherapy in combination with steroid treatment significantly improved ocular motility by reducing EOM volume in patients with active GO.",
author = "Kim, {Ji Won} and Han, {Sun Hyup} and Son, {Byeong Jae} and Rim, {Tyler Hyungtaek} and Keum, {Ki Chang} and Jinsook Yoon",
year = "2016",
month = "5",
day = "1",
doi = "10.1007/s00417-016-3280-7",
language = "English",
volume = "254",
pages = "991--998",
journal = "Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie",
issn = "0065-6100",
publisher = "Springer Verlag",
number = "5",

}

Efficacy of combined orbital radiation and systemic steroids in the management of Graves’ orbitopathy. / Kim, Ji Won; Han, Sun Hyup; Son, Byeong Jae; Rim, Tyler Hyungtaek; Keum, Ki Chang; Yoon, Jinsook.

In: Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 254, No. 5, 01.05.2016, p. 991-998.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Efficacy of combined orbital radiation and systemic steroids in the management of Graves’ orbitopathy

AU - Kim, Ji Won

AU - Han, Sun Hyup

AU - Son, Byeong Jae

AU - Rim, Tyler Hyungtaek

AU - Keum, Ki Chang

AU - Yoon, Jinsook

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Purpose: To compare the efficacy and safety of combination therapy with orbital irradiation and systemic steroids versus steroid monotherapy in the management of active Graves’ orbitopathy (GO). Methods: The clinical charts of 127 patients with active inflammation due to GO who received intravenous steroid pulse therapy as a first-line treatment with or without orbital radiotherapy between 2010 and 2014 were reviewed. Patients were divided into two treatment groups: 1) combined orbital radiotherapy and steroid pulse therapy (SRT group) and 2) steroid pulse therapy only (ST group). Primary outcome measures included clinical activity score (CAS); NOSPECS classification; ocular motility impairment; and exophthalmos at 1, 3, 6, and 12 months after treatment. The secondary outcome measure was the change in orbital, extraocular muscle (EOM), and fat volume after treatment measured by orbit computed tomography. Results: Sixty-eight patients were included in the SRT group, and 59 patients were in the ST group. In both treatments, CAS and NOSPECS were significantly reduced. In the comparison of the degree of change from baseline between the groups, the SRT group demonstrated more improvement in NOSPECS and scores of ocular motility. Orbital, EOM, and fat volume significantly decreased in the SRT group; however, only fat volume was reduced in the ST group. Compressive optic neuropathy after treatment developed in 0 % of the SRT group and 3.4 % (2/59) of the ST group. Reactivation of inflammation occurred in 11.8 % (8/68) of the SRT group and 28.8 % (17/59) of the ST group. Conclusions: Orbital radiotherapy in combination with steroid treatment significantly improved ocular motility by reducing EOM volume in patients with active GO.

AB - Purpose: To compare the efficacy and safety of combination therapy with orbital irradiation and systemic steroids versus steroid monotherapy in the management of active Graves’ orbitopathy (GO). Methods: The clinical charts of 127 patients with active inflammation due to GO who received intravenous steroid pulse therapy as a first-line treatment with or without orbital radiotherapy between 2010 and 2014 were reviewed. Patients were divided into two treatment groups: 1) combined orbital radiotherapy and steroid pulse therapy (SRT group) and 2) steroid pulse therapy only (ST group). Primary outcome measures included clinical activity score (CAS); NOSPECS classification; ocular motility impairment; and exophthalmos at 1, 3, 6, and 12 months after treatment. The secondary outcome measure was the change in orbital, extraocular muscle (EOM), and fat volume after treatment measured by orbit computed tomography. Results: Sixty-eight patients were included in the SRT group, and 59 patients were in the ST group. In both treatments, CAS and NOSPECS were significantly reduced. In the comparison of the degree of change from baseline between the groups, the SRT group demonstrated more improvement in NOSPECS and scores of ocular motility. Orbital, EOM, and fat volume significantly decreased in the SRT group; however, only fat volume was reduced in the ST group. Compressive optic neuropathy after treatment developed in 0 % of the SRT group and 3.4 % (2/59) of the ST group. Reactivation of inflammation occurred in 11.8 % (8/68) of the SRT group and 28.8 % (17/59) of the ST group. Conclusions: Orbital radiotherapy in combination with steroid treatment significantly improved ocular motility by reducing EOM volume in patients with active GO.

UR - http://www.scopus.com/inward/record.url?scp=84957934570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957934570&partnerID=8YFLogxK

U2 - 10.1007/s00417-016-3280-7

DO - 10.1007/s00417-016-3280-7

M3 - Article

C2 - 26876240

AN - SCOPUS:84957934570

VL - 254

SP - 991

EP - 998

JO - Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie

JF - Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie

SN - 0065-6100

IS - 5

ER -